Kennedy Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IVC
Invacare Corporation
IVC
|
+$18.9M |
| 2 |
Myriad Genetics
MYGN
|
+$13.7M |
| 3 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$11M |
| 4 |
Advanced Energy
AEIS
|
+$10.7M |
| 5 |
HTO
H2O America
HTO
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
REIS
Reis, Inc.
REIS
|
+$19.4M |
| 2 |
Ciena
CIEN
|
+$18.1M |
| 3 |
GPT
Gramercy Property Trust
GPT
|
+$16.4M |
| 4 |
Omnicell
OMCL
|
+$15M |
| 5 |
TGI
Triumph Group
TGI
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.58% |
| 2 | Industrials | 15.02% |
| 3 | Technology | 14.06% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Real Estate | 9.71% |
Similar funds
Kennedy Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Kennedy Capital Management held 785 positions worth $4.03B, down 25% from $5.38B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Kennedy Capital Management withdrew a net $289M in Q4 2018, closing 98 positions and reducing 379 holdings. Its most notable exit was Reis, Inc., an estimated $19.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.
Against the trend, Kennedy Capital Management opened a new position in Myriad Genetics worth $11M.
- Kennedy Capital Management's largest Q4 2018 buy was Myriad Genetics: 380,075 shares worth $11M.
- Kennedy Capital Management added most to Invacare Corporation in Q4 2018, an estimated $18.9M increase.
- Kennedy Capital Management's biggest Q4 2018 reduction was Ciena, cutting an estimated $18.1M.
- Kennedy Capital Management fully exited Reis, Inc. in Q4 2018, selling an estimated $19.4M.
- Kennedy Capital Management's ten largest holdings make up 6.7% of its $4.03B portfolio in Q4 2018.
- Kennedy Capital Management opened 69 new positions and closed 98 in Q4 2018.
- Kennedy Capital Management's portfolio value fell 25% quarter-over-quarter to $4.03B.
Based on Kennedy Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.